These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17917414)

  • 1. [In vivo siRNA delivery to tumor cells and its application to cancer gene therapy].
    Takahashi Y; Nishikawa M; Takakura Y
    Yakugaku Zasshi; 2007 Oct; 127(10):1525-31. PubMed ID: 17917414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.
    Takahashi Y; Nishikawa M; Kobayashi N; Takakura Y
    J Control Release; 2005 Jul; 105(3):332-43. PubMed ID: 15936841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor cell growth in the liver by RNA interference-mediated suppression of HIF-1alpha expression in tumor cells and hepatocytes.
    Takahashi Y; Nishikawa M; Takakura Y
    Gene Ther; 2008 Apr; 15(8):572-82. PubMed ID: 18273056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small RNA: can RNA interference be exploited for therapy?
    Wall NR; Shi Y
    Lancet; 2003 Oct; 362(9393):1401-3. PubMed ID: 14585643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.
    Keates AC; Fruehauf J; Xiang S; Li CJ
    Biotechnol Genet Eng Rev; 2008; 25():113-27. PubMed ID: 21412352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi in clinical studies.
    Kubowicz P; Żelaszczyk D; Pękala E
    Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
    Liu R; Sun J; Zhang Z; Xu Y
    Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA as a route to new cancer therapies.
    Ameyar-Zazoua M; Guasconi V; Ait-Si-Ali S
    Expert Opin Biol Ther; 2005 Feb; 5(2):221-4. PubMed ID: 15757383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene therapy of ALS with short interfering RNA].
    Yokota T
    Brain Nerve; 2007 Oct; 59(10):1187-94. PubMed ID: 17969360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.
    Chakraborty C
    Curr Drug Targets; 2007 Mar; 8(3):469-82. PubMed ID: 17348839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfering with disease: opportunities and roadblocks to harnessing RNA interference.
    Lieberman J; Song E; Lee SK; Shankar P
    Trends Mol Med; 2003 Sep; 9(9):397-403. PubMed ID: 13129706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference-based therapy and its delivery systems.
    Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK
    Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo.
    Li L; Lin X; Staver M; Shoemaker A; Semizarov D; Fesik SW; Shen Y
    Cancer Res; 2005 Aug; 65(16):7249-58. PubMed ID: 16103076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
    Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.
    He S; Zhang D; Cheng F; Gong F; Guo Y
    Mol Biol Rep; 2009 Nov; 36(8):2153-63. PubMed ID: 19117119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.